Obesity
Obesity is a medical condition characterized by excessive body fat that increases the risk of health problems, including heart disease, diabetes, and certain cancers.
Obesity: BI 456906 vs. Semaglutide
We are testing a new medication, BI 456906, in people with obesity to see how it affects liver function compared to semaglutide. This study aims to understand the potential benefits of different doses for managing obesity.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Academisch Medisch Centrum
#NDL1 Pharmacy
Abcoude, Netherlands
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.